(19)

(11)

EP 4 771 626 A2

(12)

(88) Date of publication A3: 01.05.2025 (43) Date of publication: 08.07.2026 Bulletin 2026/28 (21) Application number: 24860930.7 (22) Date of filing: 28.08.2024

(51) International Patent Classification (IPC):  G16B 20/00(2019.01) G06N 20/00(2019.01) (52) Cooperative Patent Classification (CPC): G06N 20/00; G16B 20/20; G16B 40/20; G16H 20/10 (86) International application number: PCT/US2024/044191 (87) International publication number: WO 2025/049577 (06.03.2025 Gazette 2025/10)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 29.08.2023 US 202363535263 P (71) Applicant: Foundation Medicine, Inc. Boston, MA 02210 (US)	(72) Inventors: MONTESION, Meagan Kathleen Boston, Massachusetts 02210 (US) MURUGESAN, Karthikeyan Boston, Massachusetts 02210 (US) JIN, Dexter X. Boston, Massachusetts 02210 (US) (74) Representative: CMS Cameron McKenna Nabarro Olswang LLP  Cannon Place 78 Cannon Street London EC4N 6AF London EC4N 6AF (GB)